![Amy Reilly](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amy Reilly
Contatto Relazioni con gli Investitori presso DYNE THERAPEUTICS, INC.
Posizioni attive di Amy Reilly
Società | Posizione | Inizio | Fine |
---|---|---|---|
DYNE THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 01/07/2020 | - |
Public Communications Contact | 01/07/2020 | - |
Storia della carriera di Amy Reilly
Precedenti posizioni note di Amy Reilly
Società | Posizione | Inizio | Fine |
---|---|---|---|
KALEIDO BIOSCIENCES, INC. | Contatto Relazioni con gli Investitori | 01/09/2018 | 01/05/2020 |
Public Communications Contact | 01/11/2017 | 01/05/2020 | |
THERMO FISHER SCIENTIFIC | Public Communications Contact | 01/03/2017 | 01/10/2017 |
IMMUNOGEN, INC. | Public Communications Contact | 01/10/2015 | 01/03/2017 |
CUBIST PHARMACEUTICALS INC | Public Communications Contact | 01/01/2011 | 01/01/2015 |
Formazione di Amy Reilly
Bowdoin College | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Posizioni
Public Communications Contact | 5 |
Investor Relations Contact | 2 |
Undergraduate Degree | 1 |
Settori
Health Technology | 6 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
KALEIDO BIOSCIENCES, INC. | Health Technology |
DYNE THERAPEUTICS, INC. | Health Technology |
THERMO FISHER SCIENTIFIC | Health Technology |
Aziende private | 2 |
---|---|
Cubist Pharmaceuticals LLC
![]() Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
ImmunoGen, Inc.
![]() ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Amy Reilly
- Esperienza